BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28218741)

  • 1. Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.
    Babapoor S; Wu R; Kozubek J; Auidi D; Grant-Kels JM; Dadras SS
    Lab Invest; 2017 Jun; 97(6):636-648. PubMed ID: 28218741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-depth characterization of microRNA transcriptome in melanoma.
    Kozubek J; Ma Z; Fleming E; Duggan T; Wu R; Shin DG; Dadras SS
    PLoS One; 2013; 8(9):e72699. PubMed ID: 24023765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
    Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
    Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.
    Murria Estal R; de Unamuno Bustos B; Pérez Simó G; Simarro Farinos J; Torres Navarro I; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Melanoma Res; 2021 Feb; 31(1):18-26. PubMed ID: 33234848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary study of microRNA expression in different types of primary melanoma.
    Gencia I; Baderca F; Avram S; Gogulescu A; Marcu A; Seclaman E; Marian C; Solovan C
    Bosn J Basic Med Sci; 2020 May; 20(2):197-208. PubMed ID: 31479413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-34a inhibits melanoma growth by targeting ZEB1.
    Xu Y; Guo B; Liu X; Tao K
    Aging (Albany NY); 2021 Jun; 13(11):15538-15547. PubMed ID: 34102608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis.
    Dika E; Broseghini E; Porcellini E; Lambertini M; Riefolo M; Durante G; Loher P; Roncarati R; Bassi C; Misciali C; Negrini M; Rigoutsos I; Londin E; Patrizi A; Ferracin M
    Cell Death Dis; 2021 May; 12(5):473. PubMed ID: 33980826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
    Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
    Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel miR-451a isomiR, associated with amelanotypic phenotype, acts as a tumor suppressor in melanoma by retarding cell migration and invasion.
    Babapoor S; Fleming E; Wu R; Dadras SS
    PLoS One; 2014; 9(9):e107502. PubMed ID: 25237911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microrna profiling analysis of differences between the melanoma of young adults and older adults.
    Jukic DM; Rao UN; Kelly L; Skaf JS; Drogowski LM; Kirkwood JM; Panelli MC
    J Transl Med; 2010 Mar; 8():27. PubMed ID: 20302635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
    Kitago M; Martinez SR; Nakamura T; Sim MS; Hoon DS
    Clin Cancer Res; 2009 May; 15(9):2988-94. PubMed ID: 19336521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression.
    van Kempen LC; van den Hurk K; Lazar V; Michiels S; Winnepenninckx V; Stas M; Spatz A; van den Oord JJ
    Virchows Arch; 2012 Oct; 461(4):441-8. PubMed ID: 22956368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of microRNAs and their target genes in melanomas originating from gynecologic sites.
    DiVincenzo MJ; Angell CD; Suarez-Kelly LP; Ren C; Barricklow Z; Moufawad M; Fadda P; Yu L; Backes FJ; Ring K; Mills A; Slingluff C; Chung C; Gru AA; Carson WE
    PLoS One; 2023; 18(6):e0285804. PubMed ID: 37384650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal regulation of microRNAs and related genes in pediatric β-thalassemia.
    Wang H; Chen M; Xu S; Pan Y; Zhang Y; Huang H; Xu L
    J Clin Lab Anal; 2021 Sep; 35(9):e23945. PubMed ID: 34398996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAome in decidua: a new approach to assess the maintenance of pregnancy.
    Wang Y; Lv Y; Wang L; Gong C; Sun J; Chen X; Chen Y; Yang L; Zhang Y; Yang X; Bai C; Wei Z; Li G
    Fertil Steril; 2015 Apr; 103(4):980-989.e6. PubMed ID: 25747134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
    Su BB; Zhou SW; Gan CB; Zhang XN
    J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma.
    Dika E; Riefolo M; Porcellini E; Broseghini E; Ribero S; Senetta R; Osella-Abate S; Scarfì F; Lambertini M; Veronesi G; Patrizi A; Fanti PA; Ferracin M
    J Invest Dermatol; 2020 Nov; 140(11):2260-2267. PubMed ID: 32275975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.